Related Experiment Video
Updated: May 6, 2026

10:05
Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
Published on: August 7, 2014
14.0K
Nylon Affinity Networks Capture and Sequester Two Model Bacteria Spiked in Human Plasma.
Fatema Hashemi1,2, Silvia Cachaco1,2, Rocio Prisby2
1Division of Emerging Transfusion-Transmitted Diseases, Office of Blood Research and Review, Food and Drug Administration, Silver Spring, MD 20993, USA.
Pathogens (Basel, Switzerland)
|August 28, 2025
Summary
Nylon affinity networks using Alcian Blue effectively remove bacteria from plasma, enhancing blood transfusion safety. This novel pathogen reduction technology shows promise for clinical applications.
Area of Science:
- Biotechnology
- Medical Microbiology
- Materials Science
Background:
- Bacterial contamination poses a significant risk to blood transfusion safety.
- Current pathogen reduction methods have limitations.
- Novel technologies are needed to improve the safety of blood products.
Purpose of the Study:
- To investigate the efficacy of nylon functionalized with synthetic dyes (nylon affinity networks) for capturing and removing bacteria from plasma.
- To identify the most effective synthetic dye for bacterial capture.
- To evaluate the potential of this technology for enhancing transfusion safety.
Main Methods:
- Screening of 19 synthetic dyes for bacterial capture from spiked phosphate buffer solution (PBS) and human plasma.
- Testing of the optimal dye, Alcian Blue, in sequential capture steps using varying volumes and bacterial concentrations.
- Assessment of bacterial reduction via agar plate cultures.
- Confirmation of bacterial viability on post-treatment affinity networks.
- Identification of captured plasma proteins using liquid chromatography tandem mass spectrometry.
Main Results:
- Alcian Blue demonstrated superior performance in capturing both *Escherichia coli* and *Staphylococcus epidermidis* from PBS and plasma.
- Three sequential capture steps with Alcian Blue affinity networks achieved complete bacterial depletion from plasma.
- Captured bacteria remained viable on the affinity networks.
- A small number of plasma proteins were incidentally captured by the Alcian Blue networks.
Conclusions:
- Nylon affinity networks functionalized with Alcian Blue show significant potential as a pathogen reduction technology for blood plasma.
- This method effectively removes bacteria, thereby enhancing the safety of blood transfusions.
- Further research is warranted to fully assess the clinical applicability and optimize the performance of this technology.

